Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Renewable Chemical Production Tax Credit Will Help U.S. Biotech Companies Create Jobs, BIO Says
Aug 3 2012
Washington, D.C. (Aug. 2, 2012) – Producing renewable chemicals and biobased products using homegrown biotechnology can generate additional employment...
BIO Thanks Sens. Baucus, Hatch, Senate Finance Committee for Extending Tax Policy That Drives Innovation
Aug 2 2012
Washington, D.C. (Aug. 2, 2012) –The Biotechnology Industry Organization (BIO) today thanked Sens. Max Baucus (D-Mont.) and Orrin Hatch (R-Utah) and...
BIO Issues Call for Sessions for 2013 BIO International Convention
Aug 1 2012
Washington, D.C. (August 1, 2012) – The Biotechnology Industry Organization (BIO) invites biotechnology, health care, energy, business, government...
BIO Opposes A Northern California County's New Drug Disposal Law
Jul 27 2012
Washington, D.C. (July 27, 2012) – Biotechnology Industry Organization (BIO) Vice President of Alliance Development and State Government Relations...
Biotech Leader Provides Testimony at Congressional Hearing on Sarbanes-Oxley
Jul 26 2012
Washington, D.C. (July 26, 2012) – Today, the House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary of the Sarbanes...
IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
Jul 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping Potential GENEVA, WASHINGTON, D.C. and...
BIO Praises Rep. Michael Fitzpatrick on Introduction of Fostering Innovation Act
Jul 20 2012
Washington, D.C. (July 20, 2012) – Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the Fostering Innovation Act, to update SEC...
USDA Considers “Nonbrowning” Apple
Jul 19 2012
Consumers to directly benefit from new foods improved through biotechnology WASHINGTON, D.C. (July 19, 2012) – Modern agricultural biotechnology is...
BIO Applauds U.S. Navy’s Great Green Fleet Debut
Jul 19 2012
  Navy Warships and Fighter Jets Use Advanced Biofuels and Foster U.S. Innovation Washington, D.C. (July 19, 2012) – The Biotechnology...
U.S. Farmers Continue to Prefer Biotech Crop Varieties
Jul 16 2012
Adoption of biotech cotton rose to 94 percent from last year WASHINGTON, D.C. (July 16, 2012) – Genetically engineered (GE) varieties of soybeans,...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...